牛叉诊股

[{"date":"2025.12.08","stock":"-1.33","trade":"-0.39","ind":"0.54"},{"date":"2025.12.05","stock":"0.67","trade":"-0.36","ind":"0.70"},{"date":"2025.12.04","stock":"-1.00","trade":"-1.07","ind":"-0.06"},{"date":"2025.12.03","stock":"2.38","trade":"1.34","ind":"-0.51"},{"date":"2025.12.02","stock":"-1.01","trade":"-0.75","ind":"-0.42"},{"date":"2025.12.01","stock":"2.41","trade":"1.06","ind":"0.65"},{"date":"2025.11.28","stock":"1.40","trade":"-0.86","ind":"0.34"},{"date":"2025.11.27","stock":"-3.05","trade":"0.50","ind":"0.29"},{"date":"2025.11.26","stock":"10.07","trade":"0.52","ind":"-0.15"},{"date":"2025.11.25","stock":"0.75","trade":"1.77","ind":"0.87"},{"date":"2025.11.24","stock":"1.14","trade":"0.97","ind":"0.05"},{"date":"2025.11.21","stock":"-4.71","trade":"-3.30","ind":"-2.45"},{"date":"2025.11.20","stock":"-0.72","trade":"0.07","ind":"-0.40"},{"date":"2025.11.19","stock":"-2.11","trade":"-1.77","ind":"0.18"},{"date":"2025.11.18","stock":"-2.41","trade":"-1.55","ind":"-0.81"},{"date":"2025.11.17","stock":"-0.68","trade":"-1.44","ind":"-0.46"},{"date":"2025.11.14","stock":"0.34","trade":"1.17","ind":"-0.97"},{"date":"2025.11.13","stock":"1.39","trade":"0.48","ind":"0.73"},{"date":"2025.11.12","stock":"-0.69","trade":"0.85","ind":"-0.07"},{"date":"2025.11.11","stock":"1.75","trade":"1.11","ind":"-0.39"},{"date":"2025.11.10","stock":"2.15","trade":"0.84","ind":"0.53"}]

中恒集团,上证指数,中药指数

压力支撑

该股压力位为2.97元，支撑位为2.92元。

[{"text":"\u538b\u529b\u4f4d","value":"2.97","date":1765123200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"2.92","date":1765123200,"color":"0x0b52a1"}]

多空趋势

多头行情中，并且有加速上涨趋势。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：2.4资金面打败了17%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：12月08日 20:30

机构今日流向(万元)	-2253.27	机构5日流向(万元)	-6295.08
机构10日流向(万元)	-9083.85	机构20日流向(万元)	-22053.90

机构持仓

2025-06-30 与 2024-12-31 相比，主力机构持仓量增加598.88万股，其中基金净减仓4家，主力净增仓7家，请投资者中长期谨慎为宜。

截止2025-06-30，共56家主力机构（基金48家，一般法人8家），持仓量总计120433.17万股，占流通A股36.47%
其中，基金持仓与2024-12-31相比：
增仓：9家，增持 867.82万股
减仓：13家，减持 254.48万股
新出现在主力名单中：26家，持有566.03万股
从主力名单中消失：19家，原持有81.3万股

消息面诊股

诊断结果：5.5消息面打败了54%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	资产重组	公司股权转让	2025-11-04
一般消息	高管变动	连续任职即将满六年	2025-09-29
一般消息	股东大会	临时股东大会	2025-09-13
一般消息	分红转增	不分配不转增	2025-08-30
一般消息	募资投向	公司购买资产	2025-08-30
一般消息	重大事项	关联交易	2025-08-30
一般消息	募资投向	公司购买资产	2025-08-22
一般消息	资产重组	公司股权转让	2025-07-29
利好	重大事项	参股拟上市公司或非上市公司金融机构	2025-06-30
一般消息	重大事项	关联交易	2025-04-29
一般消息	高管变动	辞去	2025-04-28
一般消息	募资投向	公司出售资产	2025-04-25
一般消息	高管变动	因个人原因	2025-04-07
一般消息	分红转增	不分配不转增	2025-03-29
一般消息	重大事项	关联交易	2025-03-29
一般消息	高管变动	因工作调整	2025-03-04
一般消息	募资投向	公司购买资产	2025-01-27
利空	业绩预告	业绩预亏	2025-01-25
利好	重大事项	参股拟上市公司或非上市公司金融机构	2024-12-31

一年消息统计

	所有消息	重大消息	非重大消息
利好	2条	0条	2条
利空	1条	0条	1条

行业面诊股

诊断结果：6.5行业面打败了82%的股票中药行业最新资金流向

近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，接近大盘。

[{"date":"2025.12.08","price":"0.54","value":"-0.39"},{"date":"2025.12.05","price":"0.70","value":"-0.36"},{"date":"2025.12.04","price":"-0.06","value":"-1.07"},{"date":"2025.12.03","price":"-0.51","value":"1.34"},{"date":"2025.12.02","price":"-0.42","value":"-0.75"},{"date":"2025.12.01","price":"0.65","value":"1.06"},{"date":"2025.11.28","price":"0.34","value":"-0.86"},{"date":"2025.11.27","price":"0.29","value":"0.50"},{"date":"2025.11.26","price":"-0.15","value":"0.52"},{"date":"2025.11.25","price":"0.87","value":"1.77"},{"date":"2025.11.24","price":"0.05","value":"0.97"},{"date":"2025.11.21","price":"-2.45","value":"-3.30"},{"date":"2025.11.20","price":"-0.40","value":"0.07"},{"date":"2025.11.19","price":"0.18","value":"-1.77"},{"date":"2025.11.18","price":"-0.81","value":"-1.55"},{"date":"2025.11.17","price":"-0.46","value":"-1.44"},{"date":"2025.11.14","price":"-0.97","value":"1.17"},{"date":"2025.11.13","price":"0.73","value":"0.48"},{"date":"2025.11.12","price":"-0.07","value":"0.85"},{"date":"2025.11.11","price":"-0.39","value":"1.11"},{"date":"2025.11.10","price":"0.53","value":"0.84"}]

上证指数,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	粤万年青	42.70%	1.15%	5.4分
2	太龙药业	30.40%	16.42%	6.2分
3	特一药业	11.12%	-7.27%	5.8分
4	嘉应制药	8.86%	-0.67%	5.0分
5	众生药业	8.04%	-9.67%	4.1分
6	江中药业	7.64%	1.94%	7.0分
7	沃华医药	7.28%	7.28%	5.9分
8	盘龙药业	6.83%	-2.13%	5.1分
9	新光药业	6.18%	5.54%	5.7分
10	金花股份	4.08%	-3.20%	4.5分
11	中恒集团	3.86%	-0.34%	5.8分
12	益盛药业	3.46%	5.22%	5.5分
13	汉森制药	2.84%	-1.43%	5.5分
14	陇神戎发	0.68%	-1.70%	5.5分
15	济川药业	0.59%	0.59%	6.6分
16	上海凯宝	-0.31%	-1.54%	5.1分
17	葵花药业	-0.47%	-1.80%	4.1分
18	启迪药业	-0.52%	-0.86%	5.0分
19	红日药业	-0.53%	1.34%	5.1分
20	华神科技	-0.92%	-2.28%	5.4分
21	贵州三力	-0.98%	0.66%	5.5分
22	信邦制药	-1.02%	1.83%	6.0分
23	精华制药	-1.13%	-2.35%	5.3分
24	天士力	-1.23%	-2.05%	5.3分
25	桂林三金	-1.38%	-2.48%	5.9分
26	亚宝药业	-1.45%	2.87%	6.1分
27	千金药业	-1.57%	-0.75%	6.2分
28	康缘药业	-1.90%	1.84%	4.8分
29	东阿阿胶	-2.05%	1.29%	5.2分
30	云南白药	-2.06%	0.94%	5.3分
31	佐力药业	-2.43%	-0.23%	5.6分
32	康恩贝	-2.72%	-0.21%	6.0分
33	方盛制药	-2.92%	1.66%	5.3分
34	奇正藏药	-3.18%	-1.12%	5.3分
35	康惠股份	-3.20%	1.59%	5.6分
36	同仁堂	-3.35%	-1.57%	4.5分
37	康美药业	-3.38%	-0.50%	5.2分
38	佛慈制药	-3.47%	-1.55%	4.8分
39	羚锐制药	-3.89%	-0.50%	5.4分
40	寿仙谷	-4.11%	-2.07%	4.4分
41	步长制药	-4.15%	-1.69%	5.3分
42	马应龙	-4.28%	0.00%	6.3分
43	昆药集团	-4.37%	-0.68%	4.8分
44	ST香雪	-4.52%	-2.16%	5.1分
45	新天药业	-4.86%	-1.49%	4.4分
46	益佰制药	-5.20%	-1.87%	5.1分
47	仁和药业	-5.22%	-0.17%	5.2分
48	广誉远	-5.25%	-2.37%	4.6分
49	华森制药	-5.33%	-4.11%	4.0分
50	白云山	-5.35%	-0.27%	5.0分
51	振东制药	-5.52%	-3.99%	3.9分
52	恩威医药	-5.67%	-3.81%	4.9分
53	片仔癀	-6.32%	-1.54%	4.7分
54	以岭药业	-6.51%	-4.77%	5.1分
55	太极集团	-6.69%	-1.29%	4.7分
56	达仁堂	-7.00%	-1.80%	5.3分
57	华润三九	-7.01%	-1.23%	4.9分
58	健民集团	-7.37%	-0.70%	5.0分
59	九芝堂	-7.68%	-2.01%	4.5分
60	贵州百灵	-8.03%	-4.01%	4.4分
61	吉林敖东	-8.15%	2.65%	5.1分
62	天目药业	-8.40%	-0.06%	5.7分
63	ST葫芦娃	-9.02%	-4.10%	4.0分
64	-	-9.81%	-4.41%	分
65	-	-10.79%	-3.04%	分
66	珍宝岛	-12.06%	-1.54%	5.0分
67	维康药业	-12.85%	-14.43%	3.5分
68	万邦德	-14.95%	-6.91%	4.5分
69	*ST长药	-23.55%	-5.38%	3.9分

<上一页 1 2 3 4 5...12 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：5.4基本面打败了33%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。

个股深一度

潜在高分红能力：弱（37.5分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 54/109 ， 57/109。

[{"date":"2025-09-30","value":"0.42","vol":"4.74"},{"date":"2025-06-30","value":"0.46","vol":"3.98"},{"date":"2025-03-31","value":"0.30","vol":"2.21"},{"date":"2024-12-31","value":"-5.99","vol":"4.80"},{"date":"2024-09-30","value":"0.17","vol":"2.91"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	0.42	0.46	0.30	-5.99	0.17
行业(%)	4.74	3.98	2.21	4.80	2.91

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"31.92","vol":"52.31"},{"date":"2025-06-30","value":"30.29","vol":"52.86"},{"date":"2025-03-31","value":"29.62","vol":"53.38"},{"date":"2024-12-31","value":"43.21","vol":"52.74"},{"date":"2024-09-30","value":"40.50","vol":"53.11"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	31.92	30.29	29.62	43.21	40.50
行业(%)	52.31	52.86	53.38	52.74	53.11

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 23/109 ， 8/109。

[{"date":"2025-09-30","value":"1.10","vol":"-7.31"},{"date":"2025-06-30","value":"2.84","vol":"-7.31"},{"date":"2025-03-31","value":"-7.92","vol":"-7.18"},{"date":"2024-12-31","value":"-26.67","vol":"-7.35"},{"date":"2024-09-30","value":"-11.03","vol":"-5.11"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	1.10	2.84	-7.92	-26.67	-11.03
行业(%)	-7.31	-7.31	-7.18	-7.35	-5.11

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"119.61","vol":"-2.54"},{"date":"2025-06-30","value":"23.59","vol":"2.98"},{"date":"2025-03-31","value":"-66.61","vol":"-37.19"},{"date":"2024-12-31","value":"-547.14","vol":"-146.29"},{"date":"2024-09-30","value":"-90.69","vol":"61.78"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	119.61	23.59	-66.61	-547.14	-90.69
行业(%)	-2.54	2.98	-37.19	-146.29	61.78

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 59/109 ， 28/109。

[{"date":"2025-09-30","value":"0.18","vol":"0.35"},{"date":"2025-06-30","value":"0.13","vol":"0.24"},{"date":"2025-03-31","value":"0.07","vol":"0.12"},{"date":"2024-12-31","value":"0.20","vol":"0.50"},{"date":"2024-09-30","value":"0.17","vol":"0.37"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.18	0.13	0.07	0.20	0.17
行业(次)	0.35	0.24	0.12	0.50	0.37

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.80","vol":"1.73"},{"date":"2025-06-30","value":"1.35","vol":"1.18"},{"date":"2025-03-31","value":"0.69","vol":"0.61"},{"date":"2024-12-31","value":"1.64","vol":"2.42"},{"date":"2024-09-30","value":"1.49","vol":"1.81"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	1.80	1.35	0.69	1.64	1.49
行业(次)	1.73	1.18	0.61	2.42	1.81

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"-17.55","vol":"9.48"},{"date":"2025-06-30","value":"1.37","vol":"20.05"},{"date":"2025-03-31","value":"-10.63","vol":"-0.23"},{"date":"2024-12-31","value":"9.06","vol":"15.64"},{"date":"2024-09-30","value":"44.90","vol":"5.86"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	-17.55	1.37	-10.63	9.06	44.90
行业	9.48	20.05	-0.23	15.64	5.86

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.66","vol":"1.02"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.13","vol":"1.45"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	1.66	-	1.13	-
行业	0.00	1.02	0.00	1.45	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 15/109 ， 42/109。

[{"date":"2025-09-30","value":"2.25","vol":"3.05"},{"date":"2025-06-30","value":"2.34","vol":"2.90"},{"date":"2025-03-31","value":"2.31","vol":"2.99"},{"date":"2024-12-31","value":"2.35","vol":"2.88"},{"date":"2024-09-30","value":"2.72","vol":"3.25"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	2.25	2.34	2.31	2.35	2.72
行业	3.05	2.90	2.99	2.88	3.25

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.97","vol":"2.21"},{"date":"2025-06-30","value":"2.06","vol":"2.13"},{"date":"2025-03-31","value":"2.02","vol":"2.22"},{"date":"2024-12-31","value":"2.02","vol":"2.11"},{"date":"2024-09-30","value":"2.35","vol":"2.43"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	1.97	2.06	2.02	2.02	2.35
行业	2.21	2.13	2.22	2.11	2.43

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 20/109 ， 21/109。

[{"date":"2025-09-30","value":"34.36","vol":"33.12"},{"date":"2025-06-30","value":"33.56","vol":"33.87"},{"date":"2025-03-31","value":"31.89","vol":"33.29"},{"date":"2024-12-31","value":"31.55","vol":"34.05"},{"date":"2024-09-30","value":"28.17","vol":"32.87"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	34.36	33.56	31.89	31.55	28.17
行业(%)	33.12	33.87	33.29	34.05	32.87

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.66","vol":"0.75"},{"date":"2025-06-30","value":"0.63","vol":"0.74"},{"date":"2025-03-31","value":"0.58","vol":"0.72"},{"date":"2024-12-31","value":"0.58","vol":"0.75"},{"date":"2024-09-30","value":"0.49","vol":"3.20"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	0.66	0.63	0.58	0.58	0.49
行业(%)	0.75	0.74	0.72	0.75	3.20

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2025年的收益，请投资者后续关注。

[{"date":"2021","yellowRectValue":"3.07","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.79","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.84","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-3.77","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[中恒集团]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]